Endovascular Repair of Ruptured Ascending Aorta Secondary to Embolized Transcatheter Aortic Valve.
Since its approval by the U.S. Food and Drug Administration in 2011, transcatheter aortic valve replacement has revolutionized the treatment of aortic valvular disease with a rapid increase in utilization. Potentially fatal aortic complications are rare, occurring in 0.2-1.1% of cases-all reported in the early perioperative period. We present a case of a late ascending aortic pseudoaneurysm with rupture secondary to erosion by an embolized transcatheter aortic valve occurring six years after implantation, which was successfully treated with a commercially available, off-the-shelf aortic endograft.